We are live on ! Find out more
WA

Winfield Associates Portfolio holdings

AUM $276M
1-Year Est. Return 15.18%
This Fund
S&P 500
This Quarter Est. Return
-4.99%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.89%
10 Year Est. Return
AUM
$276M
AUM Growth
-$23.8M
Cap. Flow
-$3.33M
Cap. Flow %
-1.2%
Top 10 Hldgs %
42.32%
Holding
160
New
5
Increased
39
Reduced
73
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Consumer Discretionary 10.5%
3 Communication Services 6.84%
4 Real Estate 4.6%
5 Financials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNT icon
51
Avient
AVNT
$3.34B
$1.29M 0.47%
26,938
LMT icon
52
Lockheed Martin
LMT
$134B
$1.28M 0.46%
2,897
+1,910
+194% +$774K
XLY icon
53
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
$1.24M 0.45%
13,350
-300
-2% -$27.5K
VEA icon
54
Vanguard FTSE Developed Markets ETF
VEA
$227B
$1.19M 0.43%
24,861
-4,487
-15% -$218K
JVAL icon
55
JPMorgan US Value Factor ETF
JVAL
$834M
$1.19M 0.43%
32,186
MUB icon
56
iShares National Muni Bond ETF
MUB
$45.2B
$1.17M 0.42%
10,643
+243
+2% +$27.4K
TGT icon
57
Target
TGT
$63.7B
$1.15M 0.42%
5,414
-288
-5% -$62.3K
BP icon
58
BP
BP
$109B
$1.14M 0.41%
38,680
+12,875
+50% +$393K
JPM icon
59
JPMorgan Chase
JPM
$947B
$1.13M 0.41%
8,284
-649
-7% -$95.8K
BBHY icon
60
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$615M
$1.12M 0.41%
22,927
-380
-2% -$18.9K
PFE icon
61
Pfizer
PFE
$141B
$1.1M 0.4%
21,247
-310
-1% -$16.1K
CIEN icon
62
Ciena
CIEN
$53.4B
$1.09M 0.4%
18,055
+522
+3% +$34.2K
XBI icon
63
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$1.09M 0.39%
12,117
-33,471
-73% -$3.09M
VOO icon
64
Vanguard S&P 500 ETF
VOO
$968B
$1.09M 0.39%
2,621
+790
+43% +$323K
CMF icon
65
iShares California Muni Bond ETF
CMF
$4.56B
$1.06M 0.38%
18,200
CRWD icon
66
CrowdStrike
CRWD
$183B
$991K 0.36%
17,456
-2,808
-14% -$131K
RITM icon
67
Rithm Capital
RITM
$5.15B
$960K 0.35%
87,400
QUAL icon
68
iShares MSCI USA Quality Factor ETF
QUAL
$46B
$940K 0.34%
6,979
-1,000
-13% -$133K
PFF icon
69
iShares Preferred and Income Securities ETF
PFF
$13.2B
$938K 0.34%
25,755
-8,800
-25% -$324K
XLV icon
70
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$937K 0.34%
6,837
+1,100
+19% +$146K
VNLA icon
71
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
$913K 0.33%
18,600
META icon
72
Meta Platforms (Facebook)
META
$1.51T
$901K 0.33%
4,053
-3,472
-46% -$868K
GSLC icon
73
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.9B
$890K 0.32%
10,000
-160
-2% -$14.1K
HYG icon
74
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$856K 0.31%
10,400
-900
-8% -$75.2K
NUV icon
75
Nuveen Municipal Value Fund
NUV
$1.9B
$854K 0.31%
89,100

Similar funds

Winfield Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Winfield Associates held 160 positions worth $276M, down 7.9% from $300M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Winfield Associates's Q1 2022 filing shows 5 new, 39 increased, 73 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Bank ETF: 4,984 shares worth $261K. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $3.09M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Winfield Associates's largest Q1 2022 buy was State Street SPDR S&P Bank ETF: 4,984 shares worth $261K.
  • Winfield Associates added most to iShares Select Dividend ETF in Q1 2022, an estimated $2.8M increase.
  • Winfield Associates's biggest Q1 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $3.09M.
  • Winfield Associates fully exited CF Industries in Q1 2022, selling an estimated $467K.
  • Winfield Associates's ten largest holdings make up 42% of its $276M portfolio in Q1 2022.
  • Winfield Associates opened 5 new positions and closed 7 in Q1 2022.
  • Winfield Associates's portfolio value fell 7.9% quarter-over-quarter to $276M.

Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.